GL1X · GenesisL1 explorer

Research workbench

Human aldose reductase mutant C303D complexed with uracil-type inhibitor.

Analyse Human aldose reductase mutant C303D complexed with uracil-type inhibitor. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2PDQ
Type
protein
Length
315 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Aldose reductase
EC
1.1.1.21
UniProt
P15121
Ligands
NAP, 47D
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAldose reductase (EC 1.1.1.21)protein31539% helix, 15% strandP15121

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • 47D · {3-[(5-chloro-1,3-benzothiazol-2-yl)methyl]-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}acetic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13120.740.8648NAP, 47D
2700.480.8420empty

Compared structures

  • 2PDQ · Human aldose reductase mutant C303D complexed with uracil-type inhibitor. · the same entry in another collection · chain A against A, TM-score 1.00
  • P15121 · AlphaFold monomer V2.0 prediction for aldo-keto reductase family 1 member B1 (P15121) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.